GTS Securities LLC Takes Position in HealthEquity, Inc. (NASDAQ:HQY)

GTS Securities LLC bought a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,493 shares of the company's stock, valued at approximately $239,000.

Several other hedge funds also recently bought and sold shares of HQY. Ameritas Investment Partners Inc. grew its stake in shares of HealthEquity by 0.3% in the fourth quarter. Ameritas Investment Partners Inc. now owns 33,856 shares of the company's stock worth $3,248,000 after acquiring an additional 88 shares in the last quarter. Smartleaf Asset Management LLC raised its stake in HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares in the last quarter. Louisiana State Employees Retirement System lifted its holdings in HealthEquity by 0.4% during the 4th quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after buying an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its position in shares of HealthEquity by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock worth $1,706,000 after acquiring an additional 100 shares in the last quarter. Finally, State of Michigan Retirement System boosted its holdings in HealthEquity by 0.5% in the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock valued at $1,988,000 after purchasing an additional 100 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company's stock.

Insiders Place Their Bets

In related news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction dated Wednesday, April 9th. The shares were sold at an average price of $77.65, for a total transaction of $446,487.50. Following the sale, the director now owns 84,969 shares of the company's stock, valued at approximately $6,597,842.85. The trade was a 6.34% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction dated Friday, April 4th. The shares were sold at an average price of $78.26, for a total transaction of $695,027.06. Following the completion of the transaction, the executive vice president now directly owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

HQY has been the subject of a number of research reports. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and reduced their price target for the company from $120.00 to $115.00 in a research report on Tuesday, March 25th. KeyCorp reduced their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. The Goldman Sachs Group dropped their price target on HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a research note on Thursday, March 27th. Barrington Research reaffirmed an "outperform" rating and set a $112.00 price target on shares of HealthEquity in a research report on Friday, April 11th. Finally, Royal Bank of Canada began coverage on HealthEquity in a report on Thursday, May 22nd. They issued an "outperform" rating and a $112.00 price objective for the company. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Buy" and an average target price of $112.33.

HealthEquity Stock Performance

Shares of NASDAQ HQY traded up $2.20 during mid-day trading on Monday, hitting $102.81. 1,303,088 shares of the company were exchanged, compared to its average volume of 811,244. The stock has a 50 day simple moving average of $89.41 and a 200-day simple moving average of $97.49. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a market cap of $8.89 billion, a price-to-earnings ratio of 94.32, a price-to-earnings-growth ratio of 1.60 and a beta of 0.45.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.